Last updated on May 2020

Study to Evaluate the Benefits for the Patient Associated With the Treatment of Plaque Psoriasis With Apremilast After Other Systemic Treatment in Conditions of Clinical Practice in Spain


Brief description of study

Observational, prospective and multicenter study in approximately 30 sites nationwide. The investigators participating in this study will be dermatologists specializing in this pathology.

The present study will include adult patients with moderate to severe plaque who have started apremilast treatment for first time 3 months (+/- 4 weeks) before their inclusion in the study, according to the specifications of the drug's prescribing information and under usual clinical practice. Recruitment will be consecutive and the reason for not including a potential candidate patient will be registered. The decision to prescribe apremilast treatment should be clearly dissociated from the inclusion of the patient in the study. Therefore, the choice of the therapeutic strategy will be made independently by the physician.

Clinical Study Identifier: NCT03539419

Find a site near you

Start Over

Hospital Dr Negrin

Las Palmas de Gran Canaria, Spain
  Connect »

Hospital Santa Luc a

Cartagena, Murcia, Spain
  Connect »

Hospital Santa Luc a

Cartagena, Murcia, Spain
  Connect »